Which laboratory values indicate liver cancer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Laboratory Values Indicating Liver Cancer

Alpha-fetoprotein (AFP) >400 ng/mL is the most established laboratory indicator of hepatocellular carcinoma (HCC), though up to 20% of HCC cases do not produce AFP even when large. 1

Primary Laboratory Markers

Alpha-Fetoprotein (AFP)

  • Normal range: 10-20 ng/mL
  • Diagnostic threshold: >400 ng/mL is generally considered diagnostic for HCC 1
  • Important limitations:
    • Only 18% of HCC patients have AFP >400 ng/mL 2
    • 46% of HCC patients have normal AFP levels <20 ng/mL 2
    • Two-thirds of HCCs <4 cm have AFP levels <200 ng/mL 1
    • A rising AFP over time, even below 400 ng/mL, is virtually diagnostic of HCC 1
    • False positives occur at 20-250 ng/mL in regenerating nodules with viral cirrhosis 1

Des-gamma-carboxy Prothrombin (DCP/PIVKA-II)

  • 67% of HCC cases have elevated levels 1
  • Critical limitation: Only 8% of small HCCs (<2 cm) show abnormal levels 1
  • Can be measured as an option when AFP is normal in cirrhotic patients (excluding those with Vitamin K deficiency) 3
  • Optimal cutoff: 40 mAU/mL 4

AFP-L3 (Lens culinaris agglutinin-reactive AFP)

  • Threshold: >10-15% of total AFP is highly specific for small HCC 5, 4
  • More specific than total AFP for detecting HCC 5
  • Correlates with tumor aggressiveness and prognosis 5

Supporting Laboratory Values for Assessment

Liver Function Tests (Standard Evaluation)

  • Liver enzymes: AST, ALT, alkaline phosphatase 3
  • Serum albumin 3
  • Bilirubin 3
  • Coagulation screen (PT/INR) 3
  • These values assess hepatic function using Child-Pugh classification, which is critical since 80% of HCC occurs in cirrhotic livers 3

Additional Markers Under Investigation

  • Neutrophil-to-lymphocyte ratio (NLR): Optimal cutoff 2.979 shows comparable diagnostic accuracy to AFP 6
  • GDF-15: Threshold 1573.23 ng/L with 81% sensitivity and 84% specificity 7
  • Glypican-3: Being extensively studied but not yet in routine clinical use 5

Clinical Algorithm for Interpretation

In cirrhotic patients:

  1. AFP >500 ng/mL (note: some guidelines use >400 ng/mL) allows diagnosis without biopsy 3
  2. AFP 200-400 ng/mL with liver mass >2 cm on imaging has high positive predictive value 8
  3. Rising AFP trend over time is diagnostic even if absolute value remains <400 ng/mL 1

Combination approach:

  • AFP + NLR combination shows the highest diagnostic performance with AUC 0.769, sensitivity 77%, and specificity 77% 6
  • Combining two or three markers (AFP, DCP, AFP-L3) increases sensitivity and diagnostic accuracy since their levels are independent 5

Critical Caveats

  • AFP alone is insufficient for surveillance due to poor sensitivity (39-65%) 9
  • AFP can be elevated in non-malignant conditions: chronic HBV/HCV, pregnancy, other cancers (cholangiocarcinoma, colon metastases, lymphoma, germ cell tumors) 2
  • Imaging findings of classic arterial enhancement are more definitive than AFP alone in the diagnostic setting 2
  • In patients with AFP <20 ng/mL, NLR shows the highest diagnostic accuracy and combination with other markers does not improve performance 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.